Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
BörsenkürzelBAX
Name des UnternehmensBaxter International Inc
IPO-datumJun 20, 2097
CEOHider (Andrew P)
Anzahl der mitarbeiter38000
WertpapierartOrdinary Share
GeschäftsjahresendeJun 20
AddresseOne Baxter Parkway
StadtDEERFIELD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl60015
Telefon12249482000
Websitehttps://www.baxter.com/
BörsenkürzelBAX
IPO-datumJun 20, 2097
CEOHider (Andrew P)